Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
The Top 7 Stocks to Buy Now: Summer 2024
04:24pm, Wednesday, 31'st Jul 2024
Catalysts are forming around a lot of the top stocks right now, making this a good time for investors to buy. Many companies are seeing a boost in their share price following strong earnings reports.
Pfizer's Diverse Portfolio And Strong Execution Earn Analyst Praise Despite Patent Concerns
02:56pm, Wednesday, 31'st Jul 2024
On Tuesday, Pfizer Inc. PFE reported second-quarter adjusted EPS of $0.60, down 11% year over year, beating the consensus of $0.46.
Merck / Pfizer Earnings Summaries: Staying With Merck For Now, Pfizer's Cost-Cutting Will Help Margins
01:59pm, Wednesday, 31'st Jul 2024
The prime culprit for yesterday's 9.8% drop in Merck was what seemed to be a rather slight slip in Gardasil revenue – Merck's HPV vaccine – which came in about $20 million below consensus. At $113
Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement
08:00am, Wednesday, 31'st Jul 2024
Funding from and collaboration with Pfizer could facilitate Telescope's growth and R&D advancement Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - Telescope Innovations Corp. (CSE: TEL
Pfizer (PFE) CFO on Entering the GLP-1 Market
04:25pm, Tuesday, 30'th Jul 2024
Pfizer (PFE) CFO Dave Denton joins Oliver Renick to discuss the company's outlook and 2Q earnings. As @pfizer continues to rally from post-pandemic lows, Denton details the company's pipeline which in
Pfizer Posts First Quarterly Revenue Growth Since Peak COVID Vaccine Sales
03:21pm, Tuesday, 30'th Jul 2024
Pfizer (PFE) shares rose Tuesday after the pharmaceutical giant beat second-quarter revenue expectations and raised its full-year guidance.
Pfizer CEO: Weight loss pill may enter regulatory studies next year
02:18pm, Tuesday, 30'th Jul 2024
CNBC's Angelica Peebles interviews Pfizer's CEO Albert Bourla to discuss the company's earnings, expectations for its new weight loss drug, and more.
Pfizer's weight loss pill may enter regulatory studies next year, says CEO Albert Bourla
02:17pm, Tuesday, 30'th Jul 2024
CNBC's Angelica Peebles interviews Pfizer's CEO Albert Bourla to discuss the company's earnings, expectations for its new weight loss drug, and more.
Final Trades: Pfizer, Bristol Meyers, Textron and Oracle
01:27pm, Tuesday, 30'th Jul 2024
The Investment Committee give you their top stocks to watch for the second half.
Earnings Alert: PYPL, GLW, PG, PFE
12:47pm, Tuesday, 30'th Jul 2024
Corning (GLW) shares fall on weak guidance. PayPal (PYPL) is trading higher on a beat and raise second quarter.
Stock Of The Day: Pfizer Pattern Offers Lessons After Better-Than-Expected Q2 Results
12:35pm, Tuesday, 30'th Jul 2024
Like many things on Wall Street, technical analysis is widely misunderstood. Many analysts try to identify chart patterns without understanding the psychology and price action that creates them.
Pfizer (PFE) Beats on Q2 Earnings & Sales, Raises 2024 View
11:35am, Tuesday, 30'th Jul 2024
Pfizer (PFE) beats second-quarter estimates for earnings and sales. It raises 2024 earnings as well as revenue expectations.
Here's What Key Metrics Tell Us About Pfizer (PFE) Q2 Earnings
10:36am, Tuesday, 30'th Jul 2024
The headline numbers for Pfizer (PFE) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
Dow Jumps 200 Points; Pfizer Earnings Top Views
10:12am, Tuesday, 30'th Jul 2024
U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Tuesday.
Options Traders Blast 2 Pharma Socks After Earnings
10:12am, Tuesday, 30'th Jul 2024
Pharmaceutical giants Merck & Co Inc (NYSE:MRK) and Pfizer Inc (NYSE:PFE) today reported second-quarter results.
